JPWO2021198774A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021198774A5 JPWO2021198774A5 JP2022560329A JP2022560329A JPWO2021198774A5 JP WO2021198774 A5 JPWO2021198774 A5 JP WO2021198774A5 JP 2022560329 A JP2022560329 A JP 2022560329A JP 2022560329 A JP2022560329 A JP 2022560329A JP WO2021198774 A5 JPWO2021198774 A5 JP WO2021198774A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sialic acid
- composition according
- daily dose
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 28
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims 20
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims 17
- 239000007864 aqueous solution Substances 0.000 claims 4
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 claims 2
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 claims 2
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 claims 2
- 241000315672 SARS coronavirus Species 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000025721 COVID-19 Diseases 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000013008 thixotropic agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003477P | 2020-04-01 | 2020-04-01 | |
| US63/003,477 | 2020-04-01 | ||
| PCT/IB2021/000200 WO2021198774A1 (en) | 2020-04-01 | 2021-03-31 | Sialic acid compositions for use in inhibiting and treating coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520703A JP2023520703A (ja) | 2023-05-18 |
| JPWO2021198774A5 true JPWO2021198774A5 (zh) | 2024-04-09 |
Family
ID=76250375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560329A Pending JP2023520703A (ja) | 2020-04-01 | 2021-03-31 | コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11813271B2 (zh) |
| EP (1) | EP4125926A1 (zh) |
| JP (1) | JP2023520703A (zh) |
| KR (1) | KR20220161413A (zh) |
| CN (1) | CN115461057A (zh) |
| AU (1) | AU2021247584B2 (zh) |
| BR (1) | BR112022019685A2 (zh) |
| CA (1) | CA3173633A1 (zh) |
| WO (1) | WO2021198774A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023104402A1 (en) | 2021-12-09 | 2023-06-15 | Frieslandcampina Nederland B.V. | Milk fraction that inhibits covid-19 infection |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| EP2364139A2 (en) * | 2008-11-10 | 2011-09-14 | Life Science Nutrition AS | Ngna compositions and methods of use |
| EP3694524A1 (en) * | 2017-10-11 | 2020-08-19 | Lifescience AS | N-acetylneuraminic acid compositions and methods of use |
| CN111481560A (zh) * | 2020-04-23 | 2020-08-04 | 菌维他(北京)医疗科技有限公司 | 唾液酸及衍生物在制备防治冠状病毒疾病的药品中的应用 |
| CN111658631A (zh) * | 2020-06-11 | 2020-09-15 | 广东盛普生命科技有限公司 | 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用 |
-
2021
- 2021-03-31 CA CA3173633A patent/CA3173633A1/en active Pending
- 2021-03-31 EP EP21729616.9A patent/EP4125926A1/en active Pending
- 2021-03-31 BR BR112022019685A patent/BR112022019685A2/pt unknown
- 2021-03-31 WO PCT/IB2021/000200 patent/WO2021198774A1/en unknown
- 2021-03-31 JP JP2022560329A patent/JP2023520703A/ja active Pending
- 2021-03-31 KR KR1020227037491A patent/KR20220161413A/ko unknown
- 2021-03-31 US US17/916,104 patent/US11813271B2/en active Active
- 2021-03-31 AU AU2021247584A patent/AU2021247584B2/en active Active
- 2021-03-31 CN CN202180027387.8A patent/CN115461057A/zh active Pending
-
2023
- 2023-11-13 US US18/389,006 patent/US20240148763A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4668513A (en) | Method for combating snoring | |
| US5801161A (en) | Pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| US8450339B2 (en) | Compositions for treatment of common cold | |
| JP5524438B2 (ja) | ロテプレドノールと抗ヒスタミン薬の新規な組み合わせ物 | |
| JP2007532663A (ja) | ニューロパシー性の糖尿病性足潰瘍を治療するためのトレプロスチニルの使用 | |
| KR101862415B1 (ko) | 상승적 항바이러스 조성물 및 이의 용도 | |
| US20030212004A1 (en) | Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis | |
| RU2488393C2 (ru) | Жидкие композиции, включающие валсартан | |
| US4789660A (en) | Insulin administration using methyl and propyl paraben | |
| US4940728A (en) | Treatment for sino-nasal congestion | |
| JP2002332229A (ja) | 感冒用組成物 | |
| CA2296231C (en) | Composition and method for treating common viral infections | |
| US5925625A (en) | Pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| US5331012A (en) | Topical pharmaceutical preparation for fever blisters and other viral infections and method of use | |
| JPWO2021198774A5 (zh) | ||
| JP7340722B2 (ja) | コバラミン化合物の経鼻投与のための医薬組成物 | |
| RU2757360C1 (ru) | Применение фосфолипидной эмульсии, содержащей эффективное количество дигидрокверцетина, лецитин и глицин для лечения воспалительных заболеваний органов дыхания | |
| ES2252751T3 (es) | Medicamento para el corazon pulmonar. | |
| CA2010085C (en) | Pentamidine solutions | |
| KR880003973A (ko) | 약리적 활성 화합물 및 용도 | |
| JPH05170663A (ja) | カルシトニン点鼻用医薬組成物 | |
| JP2014511828A (ja) | アンブロキソールを含む噴霧可能な組成物の使用 | |
| JP2002030000A (ja) | 風邪根本治療法 | |
| RU2744854C1 (ru) | Жидкая лекарственная форма для лечения и профилактики гриппа и орви | |
| KR101770752B1 (ko) | 비강 세척제 |